Syntr Health Technologies
Irvine, US · Founded 2018 · Delaware corporation
Syntr Health Technologies makes the SyntrFuge System, an FDA-cleared device that automates the processing of autologous fat (microfat) for fat grafting, body contouring, and tissue healing. The device is aimed at clinical practices—including plastic, orthopedic, wound care, gastrointestinal, and veterinary surgeons—enabling in-office fat transfer procedures.
Founders & leadership
AZ
Ahmed ZobiNamed on SEC filing
HS
Hugo SalasNamed on SEC filing
DS
Dane ShacklefordNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 2 rounds · 2018–2022
▶$795KraisedSep 2022 · 6 investors · BiotechnologyRule 506(b)
▶$795KraisedSep 2022 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hugo SalasDirector
- Dane ShacklefordDirector
- Ahmed ZobiExecutive Officer, Director
- Amount sold
- $795K
- Minimum investment
- $5K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.2MraisedJul 2021 · 23 investors · BiotechnologyRule 506(b)
▶$2.2MraisedJul 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ahmed ZobiExecutive Officer, Director
- Hugo SalasDirector
- Dane ShacklefordDirector
- Amount sold
- $2.2M
- Minimum investment
- $5K
- Sales commissions
- $8K
- Placement agents
- HUBBLE INVESTMENTS, LLC
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Syntr Health Technologies do?
- Syntr Health Technologies makes the SyntrFuge System, an FDA-cleared device that automates the processing of autologous fat (microfat) for fat grafting, body contouring, and tissue healing. The device is aimed at clinical practices—including plastic, orthopedic, wound care, gastrointestinal, and veterinary surgeons—enabling in-office fat transfer procedures.
- How much funding has Syntr Health Technologies raised?
- Syntr Health Technologies has disclosed $2.9M raised across 2 rounds.
- Where is Syntr Health Technologies headquartered?
- Syntr Health Technologies is headquartered in Irvine, US.